Optima Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Buy
286
+6
+2% +$6.13K 0.14% 123
2026
Q1
$258K Buy
280
+3
+1% +$3.04K 0.12% 137
2025
Q4
$298K Buy
+277
New +$265K 0.13% 122

Other funds holding LLY

Optima Capital's LLY Position: Q2 2026 in Review

Optima Capital increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $6.13K and bringing the position to 286 shares worth $343K. The position accounts for 0.14% of the portfolio, ranked #123.

Optima Capital first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 1,564 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Optima Capital held 286 shares of Eli Lilly worth $343K as of Q2 2026.
  • Optima Capital bought 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
  • Eli Lilly made up 0.14% of Optima Capital's portfolio in Q2 2026, its #123 holding.
  • Optima Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 1,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Optima Capital's 13F filing for Q2 2026, filed 24 Jul 2026.